CREST syndrome is a limited form of systemic sclerosis characterised by the presence of calcinosis, Raynaud's phenomenon, esophageal dysmotility, sclerodactyly, and telangiectasia. It is clinically significant as it can lead to complications such as pulmonary hypertension and gastrointestinal issues, impacting quality of life and management strategies. Early recognition and monitoring are crucial to mitigate these risks and improve patient outcomes.
Please confirm you want to block this member.
You will no longer be able to:
Please allow a few minutes for this process to complete.